Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?

Statins and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors interfere with several pathophysiological pathways of coronavirus disease 2019 (COVID-19). Statins may have a direct antiviral effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting its main pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkas, Fotios, Milionis, Haralampos, Anastasiou, Georgia, Liberopoulos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724447/
https://www.ncbi.nlm.nih.gov/pubmed/33333472
http://dx.doi.org/10.1016/j.mehy.2020.110452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724447/
https://www.ncbi.nlm.nih.gov/pubmed/33333472
http://dx.doi.org/10.1016/j.mehy.2020.110452

Ejemplares similares